Tailor Your Cell Culture Platform to Achieve Objectives & Scale Requirements

Logo
Presented by

Ann Rossi Bilodeau, Senior Bioprocess Applications Scientist, Corning Life Sciences

About this talk

The cell and gene therapy field is rapidly advancing, placing a focus on manufacturing challenges to meet the growing demand. The efficient harvest of viable cells or cell products and maintenance of native biological function influences platform and workflow choices. Established protocols for viral vector production on a range of scalable adherent platforms can be tailored to meet end objectives, taking into consideration factors such as desired yield, time to optimize the process, facility space, and media usage. Essentially, there is no ‘one-size-fits-all’ platform for upstream adherent cell culture.

Related topics:

More from this channel

Upcoming talks (2)
On-demand talks (177)
Subscribers (20859)
The Corning Scientific Seminar Series is a series of free, online technical presentations that provide novel tips, best practices and proven techniques to help advance your research. Delivered by scientists to scientists, these one-hour broadcasts offer useful information and tips for lab technicians and researchers.